Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Tables)

v2.4.0.6
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2012
Intangible Assets Tables  
Company's intangible assets consist of intellectual property, principally patents, acquired in the acquisition of ValiBio

The Company’s intangible assets consist of intellectual property, principally patents, acquired in the acquisition of ValiBio. 

 

                December 31,  
                2011  
          Accumulated     Net Carrying  
    Cost     Amortization     Value  
    $     $     $  
                         
Patents     1,642,195       119,384       1,522,811  
                         
      1,642,195       119,384       1,522,811  

 

                December 31,  
                2012  
          Accumulated     Net Carrying  
    Cost     Amortization     Value  
    $     $     $  
                         
Patents     1,666,346       236,108       1,430,238  
                         
      1,666,346       236,108       1,430,238  

 

 

Amortization Expenses

The annual estimated amortization schedule over the next five years is as follows:

2013 $ 112,507
2014 $ 112,507
2015 $ 112,507
2016 $ 112,507
2017 $ 112,507